Direxion Daily Energy Bull 2X Shares ETF
ERX
VanEck Oil Services ETF
OIH
iShares US Telecommunications ETF
IYZ
4
ProShares Ultra Materials
UYM
5
Energy Select Sector SPDR Fund
XLE
US Stock MarketDetailed Quotes
Traws Pharma (TRAW)
- 1.570
- -0.400-20.30%
Close Feb 19 16:00 ET
- 1.638
- +0.068+4.35%
Post 19:38 ET
12.55MMarket Cap-0.86P/E (TTM)
1.720High1.370Low662.86KVolume1.510Open1.970Prev Close1.01MTurnover14.42%Turnover RatioLossP/E (Static)7.99MShares4.50052wk High2.76P/B7.22MFloat Cap0.97052wk Low--Dividend TTM4.60MShs Float1751062.500Historical High--Div Yield TTM17.77%Range %0.970Historical Low1.519Avg Price1Lot Size
TRAW Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
TRAW Orderflow
Unit: --
TRAW Orderflow Trend
IntradayDayWeekMonth
No Data
Traws Pharma (TRAW) News
PMGC Holdings ELAB Offering & Patents; Traws Pharma TRAW Phase 2 Data
Moleculin Biotech MBRX Warrants Exercised; Traws Pharma TRAW Phase 2 Data
Traws Pharma Shares Are Trading Lower. The Company Announced Completion of the Clinical Analysis of Its Phase 2 Study of Ratutrelvir Versus PAXLOVID in COVID-19 Patients.
12 Health Care Stocks Moving In Thursday's Intraday Session
Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data
Traws Pharma Completes Clinical Analysis of Phase 2 Study of Ratutrelvir
Traws Pharma (TRAW) Stock Forum
$Traws Pharma (TRAW.US)$ Reuters
3m
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in Paxlovid®-Eligible and Ineligible Covid-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza! FDA Intends to Communicate Its Concerns Formally, Together With Suggested Mitigation Steps, by March 16
3m
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in Paxlovid®-Eligible and Ineligible Covid-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza! FDA Intends to Communicate Its Concerns Formally, Together With Suggested Mitigation Steps, by March 16
$Traws Pharma (TRAW.US)$ uplifting
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)